相关实验视频
Updated: Jun 12, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
在英格兰的初级保健医生中,对质子抑制剂的处方做法:一个评估评估
Kate Plehhova1, Joshua Wray2, Patricia Aluko2
1Gastrointestinals, Reckitt Benckiser Healthcare Limited, Hull, United Kingdom kate.Plehhova@reckitt.com.
英格兰的质子抑制剂 (PPI) 处方经常缺乏文档说明和指导方针的遵守. 这种过度使用需要提高意识和减轻治疗的支持,以符合临床指南.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 胃肠病学 胃肠病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 质子抑制剂 (PPI) 在全球范围内被过度使用,尽管它是最常被处方的药物类别.
- 当前的处方实践可能与已确定的临床指南不一致.
研究的目的:
- 评估英格兰的质子抑制剂 (PPI) 处方模式.
- 评估国家卫生和护理卓越研究所 (NICE) 和药物和医疗保健产品监管局 (MHRA) 准则的遵守情况.
主要方法:
- 分析来自英格兰62家初级保健全科医生 (GP) 实践的电子医疗记录 (EMR).
- 包括2021年8月至2022年6月期间持续接受PPI治疗的成年患者.
- 对抗GORD,腹不良和克洛皮多格雷尔相互作用指南的处方实践的比较.
主要成果:
- 确定了77,356名持续接受PPI治疗的患者.
- 62%的患者没有记录PPI使用的迹象,40%缺乏药物审查.
- 显著不遵守指导方针,包括PPI-clopidogrel联合处方,以及高风险患者缺乏PPI.
结论:
- 英格兰的PPI处方偏离了当前的临床指南.
- 迫切需要采取干预措施,提高人们对 PPI 过度使用的认识.
- 为优化患者护理和资源利用,对适当的抑郁症的支持至关重要.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

